Success Metrics

Clinical Success Rate
93.0%

Based on 40 completed trials

Completion Rate
93%(40/43)
Active Trials
5(8%)
Results Posted
25%(10 trials)
Terminated
3(5%)

Phase Distribution

Ph early_phase_1
2
3%
Ph phase_3
10
16%
Ph not_applicable
13
20%
Ph phase_2
16
25%
Ph phase_4
19
30%
Ph phase_1
3
5%

Phase Distribution

5

Early Stage

16

Mid Stage

29

Late Stage

Phase Distribution63 total trials
Early Phase 1First-in-human
2(3.2%)
Phase 1Safety & dosage
3(4.8%)
Phase 2Efficacy & side effects
16(25.4%)
Phase 3Large-scale testing
10(15.9%)
Phase 4Post-market surveillance
19(30.2%)
N/ANon-phased studies
13(20.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.9%

40 of 45 finished

Non-Completion Rate

11.1%

5 ended early

Currently Active

5

trials recruiting

Total Trials

64

all time

Status Distribution
Active(5)
Completed(40)
Terminated(5)
Other(14)

Detailed Status

Completed40
unknown14
Recruiting4
Terminated3
Withdrawn2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
64
Active
5
Success Rate
93.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (3.2%)
Phase 13 (4.8%)
Phase 216 (25.4%)
Phase 310 (15.9%)
Phase 419 (30.2%)
N/A13 (20.6%)

Trials by Status

recruiting46%
unknown1422%
terminated35%
completed4063%
active_not_recruiting12%
withdrawn23%

Recent Activity

Clinical Trials (64)

Showing 20 of 64 trialsScroll for more
NCT03059173Phase 3

Interest of Myo-inositol Supplementation in Women With Polycystic Ovarian Syndrome

Recruiting
NCT04944836Phase 2

Sex Hormone Supplementation and Rotator Cuff Repair: A Preliminary Randomized Trial

Recruiting
NCT07462065Phase 4

Effect Clomiphene vs Clomiphene Along With Pioglitazone on Ovarian Stimulation Rate

Recruiting
NCT07398924Not Applicable

Vaginal Estradiol and Oral Guaifenesin in Clomiphene Ovulation Induction

Completed
NCT06701071Phase 4

Evaluation of a Long Versus Short Clomid Protocol for Controlled Ovarian Stimulation

Recruiting
NCT05206448Phase 4

Randomized Controlled Trial of Combined Letrozole and Clomid (CLC II) Versus Letrozole Alone for Women With Anovulation

Active Not Recruiting
NCT06178523Phase 4

Cost-effective Treatment of Unexplained Infertility

Completed
NCT06564961Phase 3

Clomiphene Citrate in Infertile Men With Idiopathic Oligoasthenozoospermia

Completed
NCT00427700Phase 3

Induction of Ovulation With Raloxifene or Clomiphene Citrate in Polycystic Ovarian Syndrome

Completed
NCT02523898Phase 2

Metformine and CC Compared With Placebo and CC for Induction Ovulation in PCOS Patients With Insulin Resistant

Terminated
NCT02436226Phase 4

Use of Low Dose of HCG During Ovulation Induction With CC in Women With CC Resistant PCOS

Completed
NCT05231980Phase 2

Efficacy of Pentoxifylline and Alpha Lipoic Acid in PCOS Resistant to Clomiphene Citrate

Completed
NCT04177693Phase 1

Pharmacokinetics and Hepatic Safety of EGCG

Completed
NCT04306692Phase 4

Myo-inositol Versus Clomiphene Citrate in PCOS

Terminated
NCT04887402

Parameters Declaring PCO Infertile Patients Either Sensitive or Resistant to Different Doses of Clomiphene Citrate.

Unknown
NCT05106712Not Applicable

Vitamin D Supplementation and Improvement of PCOS Therapy and IVF Outcomes in Infertile Saudi Women

Unknown
NCT03566225Early Phase 1

Pioglitazone Versus Metformin as First Treatment in Infertile Women With Polycystic Ovary Syndrome

Completed
NCT04210765Phase 4

Incremental Clomiphene Citrate Doses in Successive Cycles and FSH, LH and Steroid Hormone Levels

Completed
NCT04302532Phase 4

Coenzyme q 10 and Fertility Outcome in Women With Clomiphene Resistant PCOS

Completed
NCT01718444Not Applicable

Progestin-induced Endometrial Shedding in PCOS (The PIES in PCOS Study)

Terminated

Drug Details

Intervention Type
DRUG
Total Trials
64